↑ トップへ ← 戻る

 Drug(薬物リスト) DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

101 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   250 mg ck-2017357   -   -   -   -   2件:
2,
11 
 2   3,4-diaminopyridine   -   -   -   -   3件:
11,
12,
13 
 3   500 mg ck-2017357   -   -   -   -   2件:
2,
11 
 4   Abatacept   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 5   Abatacept injection   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   2件:
11,
46 
 6   Amifampridina   -   -   -   -   1件:
11 
 7   Amifampridine   Amifampridine   D10228   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   3件:
3,
11,
12 
 8   Amifampridine phosphate   Amifampridine   D10228   2件: KCNA4, KCND2   3件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse   3件:
3,
11,
12 
 9   Anti-c5 antibody   -   -   -   -   4件:
11,
14,
62,
109 
 10   Anti-thymocyte globulin   -   -   -   -   18件:
11,
13,
14,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
164,
283,
284,
285 
 11   Argx-113   -   -   -   -   3件:
11,
35,
63 
 12   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 13   B-peptide-crm197 conjugate   -   -   -   -   1件:
11 
 14   Bbr 2778   -   -   -   -   2件:
11,
13 
 15   Belimumab   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   8件:
11,
43,
44,
46,
49,
51,
53,
222 
 16   Benlysta (belimumab)   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
11,
49,
53,
222 
 17   Benlysta® (belimumab)   Belimumab   D03068   1件: TNFSF13B   4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   2件:
11,
222 
 18   Bortezomib   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331 
 19   Carmustine   Carmustine   D00254   -   -   5件:
11,
13,
14,
28,
60 
 20   Cellcept   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   3件:
11,
42,
49 
 21   Cellcept 500 mg   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
11 
 22   Cellcept 500 mg tablets   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
11 
 23   Cfz533   -   -   -   -   4件:
11,
46,
49,
53 
 24   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 25   Cv-mg01   -   -   -   -   1件:
11 
 26   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 27   Cytarabine   Cytarabine   D00168, D03046, D03637   -   -   6件:
11,
13,
14,
25,
49,
60 
 28   Descartes-08   -   -   -   -   1件:
11 
 29   Eculizumab   Eculizumab   D03940   1件: C5   7件: Complement and coagulation cascades, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Pertussis, Prion diseases, Staphylococcus aureus infection, Systemic lupus erythematosus   7件:
11,
13,
14,
62,
109,
222,
223 
 30   Efalizumab   Efalizumab   D03959   1件: ITGAL   11件: Cell adhesion molecules (CAMs), Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis   8件:
11,
13,
37,
46,
53,
61,
95,
96 
 31   Efedrina   Ephedrine   D00124   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
11 
 32   En101   -   -   -   -   1件:
11 
 33   Ephedrine   Ephedrine   D00124   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
11 
 34   Ephedrine hydrochloride   Ephedrine   D00124   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
11 
 35   Etoposide   Etoposide   D00125, D04107   2件: TOP2A, TOP2B   1件: Platinum drug resistance   11件:
11,
13,
14,
26,
28,
34,
60,
65,
85,
164,
331 
 36   Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse   -   -   -   -   1件:
11 
 37   Gamunex 10%   Immune globulin human   -   -   -   1件:
11 
 38   Gb-0998 (intravenous immunoglobulin)   Immune globulin human   -   -   -   1件:
11 
 39   Gm-csf   Regramostim   D05712   1件: CSF2RA   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer   4件:
11,
46,
51,
229 
 40   Granulocyte-macrophage colony-stimulating factor (gm-csf)   Regramostim   D05712   1件: CSF2RA   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer   1件:
11 
 41   Gsk1550188   -   -   -   -   3件:
11,
49,
222 
 42   Hematopoietic stem cell transplantation   -   -   -   -   12件:
11,
13,
14,
19,
20,
35,
46,
49,
51,
96,
234,
285 
 43   Hidrocloruro de efedrina   Ephedrine   D00124   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
11 
 44   Hizentra ®   -   -   -   -   1件:
11 
 45   Human normal immunoglobulin   Immune globulin human   -   -   -   8件:
11,
13,
14,
43,
45,
50,
63,
65 
 46   Human normal immunoglobulin (iv)   Immune globulin human   -   -   -   4件:
11,
14,
63,
65 
 47   Human normal immunoglobulin g (igg)   Immune globulin human   -   -   -   1件:
11 
 48   Igiv-c   -   -   -   -   1件:
11 
 49   Immune globulin   -   -   -   -   3件:
11,
13,
14 
 50   Immune globulin (human), 10% caprylate/chromatography purified   Immune globulin human   -   -   -   1件:
11 
 51   Immune globulin (human), 10% caprylate/chromatography purified (igiv-c)   Immune globulin human   -   -   -   1件:
11 
 52   Immunoglobulin g   Immune globulin human   -   -   -   7件:
11,
13,
14,
49,
50,
63,
65 
 53   Influenza vaccine   -   -   -   -   4件:
11,
13,
46,
84 
 54   Intravenous immuneglobulin   -   -   -   -   1件:
11 
 55   Intravenous immunoglobulin   Immune globulin human   -   -   -   16件:
2,
11,
14,
17,
18,
35,
38,
39,
49,
51,
63,
65,
85,
164,
296,
309 
 56   Ivig   Immune globulin human   -   -   -   12件:
11,
13,
14,
17,
18,
50,
51,
63,
65,
85,
164,
296 
 57   Leflunomide   Leflunomide   D00749   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   9件:
11,
40,
46,
49,
53,
66,
224,
271,
300 
 58   M281   -   -   -   -   2件:
11,
61 
 59   Mabthera   -   -   -   -   15件:
11,
13,
35,
46,
50,
51,
53,
61,
63,
64,
65,
83,
162,
222,
271 
 60   Magnesium   Magnesium   -   -   -   15件:
6,
11,
13,
46,
64,
93,
97,
166,
225,
235,
284,
291,
296,
297,
298 
 61   Magnesium sulfate   Magnesium sulfate   D01108   -   -   3件:
11,
296,
297 
 62   Melphalan   Melphalan   D00369   -   -   14件:
11,
13,
14,
19,
20,
28,
60,
62,
65,
96,
164,
234,
284,
285 
 63   Mestinon   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   3件:
3,
6,
11 
 64   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 65   Monarsen   -   -   -   -   1件:
11 
 66   Monitor   Methamidophos   -   -   -   12件:
2,
11,
13,
19,
46,
49,
58,
70,
85,
98,
298,
300 
 67   Mutagrip   -   -   -   -   2件:
11,
13 
 68   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 69   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 70   Mycophenolate mofetil (cellcept)   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
11,
13 
 71   Mycophenolate mofetil [cellcept]   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
11 
 72   Mycophenolic acid   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   7件:
11,
49,
51,
60,
66,
96,
222 
 73   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 74   Pixantrone   Pixantrone   D05522   2件: TOP2A, TOP2B   1件: Platinum drug resistance   2件:
11,
13 
 75   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 76   Prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 77   Prednisone - azathioprine   Azathioprine   D00238, D03033   -   -   1件:
11 
 78   Prednisone alone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
11,
66 
 79   Privigen   Immune globulin human   -   -   -   4件:
11,
14,
51,
65 
 80   Pyridostigmine   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   4件:
3,
6,
11,
256 
 81   Raptiva 100 mg/ml powder and solvent for solution for injection   Efalizumab   D03959   1件: ITGAL   11件: Cell adhesion molecules (CAMs), Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis   7件:
11,
13,
46,
53,
61,
95,
96 
 82   Ravulizumab   Ravulizumab   D11054   1件: C5   7件: Complement and coagulation cascades, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Pertussis, Prion diseases, Staphylococcus aureus infection, Systemic lupus erythematosus   3件:
11,
62,
109 
 83   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 84   Rituximab (rituxan)   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
11 
 85   Rozanolixizumab   Rozanolixizumab   -   -   -   2件:
11,
14 
 86   Rvt-1401   -   -   -   -   1件:
11 
 87   Salbutamol   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
3,
11,
49,
85,
86,
228,
256,
299 
 88   Salbutamol 4mg tablet   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
11 
 89   Sodium chloride   Sodium chloride   D02056   -   -   13件:
6,
11,
13,
14,
34,
46,
51,
168,
193,
227,
228,
288,
299 
 90   Sodium chloride solution   Sodium chloride   D02056   -   -   3件:
11,
13,
228 
 91   Soliris   Eculizumab   D03940   1件: C5   7件: Complement and coagulation cascades, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Pertussis, Prion diseases, Staphylococcus aureus infection, Systemic lupus erythematosus   7件:
11,
13,
14,
62,
109,
222,
223 
 92   Subcutaneous immunoglobulins   -   -   -   -   1件:
11 
 93   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 94   Symptomatic treatment, steroids, immunosuppressive agents, plasma exchange(pe), intravenous immunoglobulin(ivig)   Immune globulin human   -   -   -   1件:
11 
 95   T-peptide-crm197 conjugate   -   -   -   -   1件:
11 
 96   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 97   Tacrolimus capsule   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   1件:
11 
 98   Tetanus vaccin   -   -   -   -   1件:
11 
 99   Ucb7665   -   -   -   -   2件:
11,
63 
 100   Velcade®   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   3件:
11,
46,
49 
 101   Zilucoplan (ra101495)   -   -   -   -   2件:
11,
62 

先頭へ